PHARMACYTE BIOTECH, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
PHARMACYTE BIOTECH, INC. (PMCB) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $28.00 thousand for the 12-month period ending 2025-04-30, per its 10-K filed 2026-07-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-07-29
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $28.00K.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2024 was -$1.04M, a 319.91% decline from fiscal 2023.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2023 was $470.94K.
- PHARMACYTE BIOTECH, INC. effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2022 was -$739.80K, a 176.33% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-04-30 | $28.00K 10-K · filed 2026-07-29 |
| 2024-04-30 | -$1.04M 10-K · filed 2025-08-11 |
| 2023-04-30 | $470.94K 10-K · filed 2024-08-13 |
| 2022-04-30 | -$739.80K 10-K · filed 2023-07-31 |
| 2021-04-30 | $969.24K 10-K · filed 2022-07-28 |
| 2020-04-30 | $1.34M 10-K · filed 2021-08-10 |
| 2019-04-30 | $952.17K 10-K · filed 2020-08-13 |
| 2018-04-30 | $1.71M 10-K · filed 2019-08-13 |
| 2017-04-30 | $1.70M 10-K · filed 2018-07-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |